Skip to main content
. 2021 Apr 9;13(8):1801. doi: 10.3390/cancers13081801

Figure 2.

Figure 2

(A) Prognostic genomic alterations identified in ATLL. Red stars denote alterations related to prognosis in ATLL. (B) Difference of PD-L1 expression patterns on ATLL prognosis. Left: PD-L1 can be expressed through genomic alterations, including the amplification and 3’UTR disruption of PD-L1 on the surface of ATLL cells. Right: stromal cells in the tumor-microenvironment express PD-L1 and the cases are associated with favorable prognosis.